Alx Oncology Holdings  Financial Flexibility Index

Latest as of June 2026: -0.65x

Alx Oncology Holdings  financial flexibility index. Alx Oncology Holdings  (ALXO) has a Financial Flexibility Index of -0.65x as of June 2026. Free cash flow of $-16.04 Million (operating CF $-16.06 Million minus capex $17.00K) represents -1% of total liabilities ($24.63 Million).

Financial Flexibility Index

-0.65x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-16.04 Million
Operating CF − Capex

Total Liabilities

$24.63 Million
USD

Capital Expenditures

$17.00K
USD

Financial Flexibility Index of Alx Oncology Holdings  (2018–2025)

Financial flexibility index of Alx Oncology Holdings  from 2018 to 2025. Historical Financial Flexibility Index trend for Alx Oncology Holdings  across 8 annual periods. Explore Alx Oncology Holdings  cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Alx Oncology Holdings  Financial Flexibility Index by Year (2018–2025)

Alx Oncology Holdings  financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Alx Oncology Holdings . For the full cash flow conversion analysis, see ALXO cash generation efficiency.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -2.54x $-83.93 Million $-84.14 Million $33.06 Million ▲ +28.6%
2024 -3.56x $-121.47 Million $-121.91 Million $34.16 Million ▼ -45.6%
2023 -2.44x $-129.09 Million $-130.36 Million $52.84 Million ▼ -19.7%
2022 -2.04x $-87.80 Million $-89.22 Million $43.02 Million ▲ +44.7%
2021 -3.69x $-63.18 Million $-68.10 Million $17.13 Million ▲ +40.2%
2020 -6.16x $-38.26 Million $-38.29 Million $6.21 Million ▼ -385.6%
2019 -1.27x $-13.90 Million $-14.25 Million $10.95 Million ▲ +79.7%
2018 -6.24x $-12.54 Million $-13.19 Million $2.01 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities